US 11,730,906 B2
Acclimization therapy for first time CPAP and NIV users
Philip Rodney Kwok, Sydney (AU); Ron Richard, Escondido, CA (US); Rohan Mullins, Sydney (AU); Chee Keong Phuah, Sydney (AU); Karthikeyan Selvarajan, Sydney (AU); Adrian Barnes, Sydney (AU); Thomas Evan Miller, Pittsford, NY (US); and David Richard Vorreiter, Sydney (AU)
Assigned to ResMed Pty Ltd., Bella Vista (AU)
Filed by ResMed Pty Ltd, Bella Vista (AU)
Filed on Sep. 30, 2020, as Appl. No. 17/38,039.
Application 17/038,039 is a division of application No. 15/593,563, filed on May 12, 2017, granted, now 10,821,242.
Application 15/593,563 is a division of application No. 11/921,644, granted, now 9,682,207, issued on Jun. 20, 2017, previously published as PCT/AU2006/000822, filed on Jun. 14, 2006.
Claims priority of application No. 2005903089 (AU), filed on Jun. 14, 2005; application No. 2005906122 (AU), filed on Nov. 4, 2005; and application No. 2005906193 (AU), filed on Nov. 8, 2005.
Prior Publication US 2021/0008308 A1, Jan. 14, 2021
Int. Cl. A61M 16/00 (2006.01); A61M 16/06 (2006.01)
CPC A61M 16/0051 (2013.01) [A61M 16/0069 (2014.02); A61M 16/024 (2017.08); A61M 16/06 (2013.01); A61M 2016/0021 (2013.01); A61M 2016/0027 (2013.01); A61M 2016/0036 (2013.01); A61M 2205/15 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/80 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of acclimatizing a patient to provide continuous positive airway pressure (CPAP) therapy, including operating a device comprising a blower and a controller for treating sleep disordered breathing (SDB), wherein said device provides continuous positive airway pressure to the patient during sleep via a mask configured to provide a seal with respect to airways of the patient, the method comprising:
applying therapeutic pressure at a first therapeutic pressure during a treatment session;
monitoring a mask pressure within the mask during application of the first therapeutic pressure;
calculating a difference between the first therapeutic pressure and the mask pressure;
comparing the difference to a first threshold representing an acceptable level of leak;
generating a first signal in response to said comparing and indicative of performance of the seal;
in response to said first signal indicating a fault in the seal, increasing the applied therapeutic pressure above the first therapeutic pressure during the treatment session; and
based on a difference between the mask pressure at the applied first therapeutic pressure and the mask pressure at the applied increased therapeutic pressure being less than a second threshold, decreasing the applied therapeutic pressure to below the first therapeutic pressure during the treatment session in order to improve the seal of the mask against the patient's face.